A Message to Our Customers and Partners Regarding COVID-19

Aktuelle Nachrichten

Nanopharm to Host Webinar on April 21st Discussing In-Vitro Dissolution Testing for Orally-Inhaled Drug Products Mehr zu Lesen
Aptar Requests U.S. FDA Emergency Use Authorization for N95 Filtering Facepiece Respirator Decontamination with ActivShieldTM Mehr zu Lesen
Aptar an Essential Partner to the Food, Healthcare and Consumer Products Industries During COVID-19 Pandemic Mehr zu Lesen
Alle Neuigkeiten anzeigen